BeStock  
Stocks › IDYA

IDEAYA Biosciences IDYA

US equityMarket cap rank #2335
$38.06 +$0.70 (+1.87%)
Pre-market · Oct 6, 4:40 am ET · After hours $38.06 0.00%
Open$37.57
Prev close$37.36
Day range$37.04 – $38.26
Volume658.0K
Market cap$3.67B
P/E (TTM)–
Dividend yield–

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Ending Cash Balance $273.87M $158.80M $113.84M $299.73M $115.45M
-Change In Other Working Capital -$8.86M -$587,000.00 -$8.14M – –
-Change in Other Current Liabilities $707,000.00 $686,000.00 $669,000.00 $648,000.00 $629,000.00
-Change in Payables and Accrued Expense $16.68M $5.78M -$5.66M $8.70M $4.48M
-Change in Prepaid Assets -$1.05M $3.03M -$5.56M $192,000.00 -$500,000.00
Change in Working Capital $7.48M $8.90M -$18.69M $11.71M $4.61M
Net Income from Continuing Operations -$112.45M -$98.54M -$83.27M $119.24M -$77.49M
Depreciation & Depletion & Amortization $1.12M $1.14M $1.20M $1.03M $1.23M
Net cash flow from continuing operations -$88.21M -$75.17M -$90.50M $142.21M -$62.47M
Operating Cash Flow -$88.21M -$75.17M -$90.50M $142.21M -$62.47M
Net cash flow from investing -$155.93M $118.95M -$97.53M $41.77M $45.92M
Net PPE Purchase and Sale -$866,000.00 -$967,000.00 -$333,000.00 -$42,000.00 -$663,000.00
Net Investment Purchase and Sale -$155.07M $119.92M -$97.19M $41.81M $46.58M
Net Change in Cash $115.07M $44.96M -$185.89M $184.28M -$15.35M
Beginning Cash Balance $158.80M $113.84M $299.73M $115.45M $130.80M
Free Cash Flow -$89.08M -$76.14M -$90.83M $142.17M -$63.14M
Proceeds from Stock Option Exercised $142.77M $1.19M $2.18M $384,000.00 $1.23M
Net Common Stock Issuance $216.44M -$9,000.00 -$46,000.00 -$83,000.00 -$25,000.00
Net Cash Flow from Continuing Financing Activities $359.21M $1.18M $2.13M $301,000.00 $1.21M
Net Cash Flow from Continuing Investing Activities -$155.93M $118.95M -$97.53M $41.77M $45.92M
Financing Cash Flow $359.21M $1.18M $2.13M $301,000.00 $1.21M

Discussion

No comments yet — be the first to weigh in on IDYA.

Leave a comment

Scroll to Top